Literature DB >> 16381082

Using simulation to estimate the cost effectiveness of improving ambulance and thrombolysis response times after myocardial infarction.

D Chase1, P Roderick, K Cooper, R Davies, T Quinn, J Raftery.   

Abstract

OBJECTIVES: To quantify the health gains and costs associated with improving ambulance and thrombolysis response times for acute myocardial infarction.
DESIGN: A computer simulation model. PATIENTS/SETTINGS: Patients experiencing acute myocardial infarction in England.
INTERVENTIONS: Improving the ambulance response time to 75% of calls reached within 8 minutes and the hospital arrival to thrombolysis time interval (door-to-needle time) to 75% receiving it within 30 minutes and 20 minutes, compared to best estimates of response times in the mid-1990s. MAIN OUTCOME MEASURES: Deaths prevented, life years saved, and discounted cost per life year saved.
RESULTS: Improving the ambulance response to 75% of calls within 8 minutes resulted in an estimate of 5 deaths prevented or 57 life years saved per million population per year, with a discounted incremental cost per life year saved of 8540 pounds sterling over 20 years. The corresponding benefit of improving the door-to-needle time to 75% of myocardial infarction patients within 30 minutes was an estimated 2 deaths prevented and 15 life years saved per million population per year, with a discounted incremental cost per life year saved of between 10,150 pounds sterling to 54,230 pounds sterling over 20 years. Little further gain was associated with reaching the 20 minute target. Combining ambulance and thrombolysis targets resulted in 70 life years saved per million population per year.
CONCLUSIONS: Improving ambulance response times appears to be cost effective. Reducing door-to-needle time will have a smaller effect at an uncertain cost. Further benefits may be gained from reducing the time from onset of symptoms to starting thrombolysis.

Entities:  

Mesh:

Year:  2006        PMID: 16381082      PMCID: PMC2564138          DOI: 10.1136/emj.2004.023036

Source DB:  PubMed          Journal:  Emerg Med J        ISSN: 1472-0205            Impact factor:   2.740


  18 in total

Review 1.  NICE: faster access to modern treatments? Analysis of guidance on health technologies.

Authors:  J Raftery
Journal:  BMJ       Date:  2001-12-01

2.  Chest pain units.

Authors:  Mike Clancy
Journal:  BMJ       Date:  2002-07-20

3.  "Heartstart Scotland"--initial experience of a national scheme for out of hospital defibrillation.

Authors:  S M Cobbe; M J Redmond; J M Watson; J Hollingworth; D J Carrington
Journal:  BMJ       Date:  1991-06-22

4.  ISIS-2: 10 year survival among patients with suspected acute myocardial infarction in randomised comparison of intravenous streptokinase, oral aspirin, both, or neither. The ISIS-2 (Second International Study of Infarct Survival) Collaborative Group.

Authors:  C Baigent; R Collins; P Appleby; S Parish; P Sleight; R Peto
Journal:  BMJ       Date:  1998-05-02

5.  Safety and efficacy of nurse initiated thrombolysis in patients with acute myocardial infarction.

Authors:  Asif Qasim; Kerry Malpass; Daniel J O'Gorman; Mary E Heber
Journal:  BMJ       Date:  2002-06-01

6.  The development of a simulation model of the treatment of coronary heart disease.

Authors:  Keith Cooper; Ruth Davies; Paul Roderick; Debbie Chase; James Raftery
Journal:  Health Care Manag Sci       Date:  2002-11

7.  Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour.

Authors:  E Boersma; A C Maas; J W Deckers; M L Simoons
Journal:  Lancet       Date:  1996-09-21       Impact factor: 79.321

Review 8.  Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials.

Authors:  Ellen C Keeley; Judith A Boura; Cindy L Grines
Journal:  Lancet       Date:  2003-01-04       Impact factor: 79.321

Review 9.  Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group.

Authors: 
Journal:  Lancet       Date:  1994-02-05       Impact factor: 79.321

10.  Impact of a region-wide approach to improving systems for heart attack care: the West Midlands thrombolysis project.

Authors:  Tom Quinn; Teresa F Allan; John Birkhead; Rod Griffiths; Sylvia Gyde; R Gordon Murray
Journal:  Eur J Cardiovasc Nurs       Date:  2003-07       Impact factor: 3.908

View more
  3 in total

Review 1.  A review of health care models for coronary heart disease interventions.

Authors:  K Cooper; S C Brailsford; R Davies; J Raftery
Journal:  Health Care Manag Sci       Date:  2006-11

2.  Decreased length of stay after addition of healthcare provider in emergency department triage: a comparison between computer-simulated and real-world interventions.

Authors:  Theodore Eugene Day; Abdul Rahim Al-Roubaie; Eric Jonathan Goldlust
Journal:  Emerg Med J       Date:  2012-03-07       Impact factor: 2.740

3.  Support and Assessment for Fall Emergency Referrals (SAFER 1) trial protocol. Computerised on-scene decision support for emergency ambulance staff to assess and plan care for older people who have fallen: evaluation of costs and benefits using a pragmatic cluster randomised trial.

Authors:  Helen Snooks; Wai-Yee Cheung; Jacqueline Close; Jeremy Dale; Sarah Gaze; Ioan Humphreys; Ronan Lyons; Suzanne Mason; Yasmin Merali; Julie Peconi; Ceri Phillips; Judith Phillips; Stephen Roberts; Ian Russell; Antonio Sánchez; Mushtaq Wani; Bridget Wells; Richard Whitfield
Journal:  BMC Emerg Med       Date:  2010-01-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.